Brazil Generics Market Forecast to 2012
Format : Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jan, 2011| No. of Pages : 60
1. Analyst View
2. Research Methodology
3. Market Overview
4. Market Drivers
4.1 Strong Investments
4.2 Government Initiatives
4.3 Patent Expiries
4.4 Aging Population
4.5 Increasing Prescription Rate
5. Industry Performance
5.1 Market Size & Growth
5.2 Pharma Market Vs Generics
5.3 By Therapeutics
5.3.1 Antiretroviral
5.3.2 Oral Contraceptives
5.3.3 Erectile Dysfunction
5.3.4 Anti-thrombotics
5.3.5 Cardiovascular Drugs
5.3.6 Anti-diabetics
6. Market Trends
6.1 Increasing Share of Foreign Firms
6.2 Rising Generic Registrations
6.3 Global Expansion
6.4 Focus on Generic Active Ingredients
7. Regulatory Environment
8. Industry Restraints & RNCOS Recommendation
8.1 Dependence on Imported Raw Materials
8.2 Over-reliance of Domestic Generic Firms on Domestic Market
8.3 Lack of Awareness & Slow Acceptance by Physicians
8.4 Prevalence of ‘Similar Drugs’
8.5 Counterfeit Drugs
9. Key Players
9.1 EMS Sigma Pharma
9.2 Medley
9.3 Eurofarma Laboratories Ltd
9.4 Aché Pharmaceutical Laboratories S/A
9.5 Ranbaxy